Daventry Group, LP Charles River Laboratories International, Inc. Transaction History
Daventry Group, LP
- $251 Million
- Q3 2024
A detailed history of Daventry Group, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Daventry Group, LP holds 106,823 shares of CRL stock, worth $19.9 Million. This represents 8.37% of its overall portfolio holdings.
Number of Shares
106,823
Previous 119,695
10.75%
Holding current value
$19.9 Million
Previous $24.7 Million
14.9%
% of portfolio
8.37%
Previous 11.04%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$950 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$698 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$398 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$362 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...